Dr. Centor discusses the cost-effectiveness of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in the treatment of patients with type 2 diabetes with Drs. Neda Laiteerapong and Aaron Winn.

First Line Drug Therapy for Type 2 Diabetes

Each Annals On Call podcast features Dr. Bob Centor discussing and debating a clinically influential article published in Annals of Internal Medicine with a guest expert.

Medicine

Science & Medicine

Health & Fitness

Dr. Centor discusses the use of use of cystatin C in estimating glomerular filtration rate with Dr. Joel Topf.

The Value of Cystatin C Measurement

Dr. Centor discusses the current increase in cases of dengue with Drs. Davidson Hamer and Ralph Huits.

A Resurgence of Dengue

Dr. Centor discusses the adverse events associated with checkpoint inhibitors with Drs. Reaford Blackburn Jr. and Brian C. Westbrook.

Checkpoint Inhibitors: What Generalists Need to Know

Dr. Centor discusses how to go beyond statistical significance testing when interpreting study findings with Dr. David Savitz.

Improving Research Reports: Avoiding p-Values

Dr. Centor discusses the real-world complications of lung cancer screening with Drs. Katharine A. Rendle and Anil Vachani.

First Line Drug Therapy for Type 2 Diabetes

Download our free app to listen on your phone